These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5990092)

  • 41. Effect of a monoamine oxidase inhibitor on blood ammonia and gastric secretion in dogs: II. Dogs with side-to-side and end-to-side portacaval anastomosis.
    Kowalewski K; Bondar GF
    Can J Surg; 1966 Jan; 9(1):99-103. PubMed ID: 5900272
    [No Abstract]   [Full Text] [Related]  

  • 42. A technique for portarenal transposition in dogs.
    Ono H; Kojima Y; Brown H; McDermott WV
    Surgery; 1968 Apr; 63(4):653-7. PubMed ID: 5645384
    [No Abstract]   [Full Text] [Related]  

  • 43. Basal and stimulated gastric secretion in man with cirrhosis with and without portacaval shunt.
    Alderman SJ; Keiter JE; Chandler JG; Rosen H; Orloff MJ
    Surg Forum; 1969; 20():363-5. PubMed ID: 5383088
    [No Abstract]   [Full Text] [Related]  

  • 44. [Extragastric factors of hypersecretion].
    Ramírez Mata M
    Rev Gastroenterol Mex; 1976; 41(2):55-7. PubMed ID: 1029865
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of portacaval shunting on gastric secretion in cirrhotic dogs.
    HEIN MF; SILEN W; SKILLMAN JJ; HARPER HA
    Gastroenterology; 1963 May; 44():637-41. PubMed ID: 13953414
    [No Abstract]   [Full Text] [Related]  

  • 46. Mechanism of gastric hypersecretion following portacaval transposition.
    KOHATSU S; GWALTNEY JA; NAGANO K; DRAGSTEDT LR
    Am J Physiol; 1959 Apr; 196(4):841-3. PubMed ID: 13637225
    [No Abstract]   [Full Text] [Related]  

  • 47. Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition.
    Lo MW; Effeney DJ; Pond SM; Silber BM; Riegelman S
    J Pharmacol Exp Ther; 1982 May; 221(2):512-5. PubMed ID: 7077541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical creation of portacaval shunts during temporary intestinal arterial and venous occlusion in dogs.
    Allen SW; Laflamme DP; Huber TL; Prasse KW
    Am J Vet Res; 1996 Apr; 57(4):588-91. PubMed ID: 8712529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of portacaval transposition on renal and adrenal function.
    Mito M; Pikula JV; McDermott WV
    Surg Gynecol Obstet; 1966 Dec; 123(6):1289-96. PubMed ID: 5953962
    [No Abstract]   [Full Text] [Related]  

  • 50. The metabolic changes after portacaval shunt.
    Martini GA
    Acta Gastroenterol Belg; 1971 Feb; 34(2):216-31. PubMed ID: 5565413
    [No Abstract]   [Full Text] [Related]  

  • 51. Protection against hypertension due to renal allograft rejection by portacaval transposition and renal artery stenosis in dogs.
    Schwartz DT
    Surgery; 1968 Dec; 64(6):1092-5. PubMed ID: 4301781
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of portal hypertension. Indications for and methods of portacaval shunt in the cirrhotic patient].
    Maillard JN; Flamant Y
    Minerva Med; 1978 Apr; 69(17):1167-70. PubMed ID: 662146
    [No Abstract]   [Full Text] [Related]  

  • 53. The "H-graft" in portacaval shunt in dogs.
    Grga A; Maticić Z; Hlevnjak D; Hofman B
    Mater Med Pol; 1994; 26(3):109-12. PubMed ID: 7603080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term effect of arterialization of the portal vein on the sinusoidal pressure in dogs with portacaval shunt.
    Arif S; Butt K; Dennis C; Lam A; Minkowitz S; Babich A; Adamsons RJ
    Surg Forum; 1977; 28():406-7. PubMed ID: 617484
    [No Abstract]   [Full Text] [Related]  

  • 55. [On the problem of gastric juice secretion and gastroduodenal ulcer in portal hypertension in liver cirrhosis and after portercaval shunt operations].
    SCHRIEFERS KH; SCHREIBER HW; ESSER G
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963; 302():702-15. PubMed ID: 13987049
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of portacaval transposition on the early intestinal phase of gastric secretion.
    SOUTHWELL JM; BAKER DM; WINNER RB; CLARKE JS
    Surg Forum; 1961; 12():278-9. PubMed ID: 13915468
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of portacaval transposition on Heidenhain pouch secretion in response to various stimuli.
    CLARKE JS; HOFFS M; EL FARRA S
    Surg Forum; 1960; 10():134-8. PubMed ID: 13810509
    [No Abstract]   [Full Text] [Related]  

  • 58. Increased histamine synthesis: a possible final common pathway in gastric acid hypersecretion.
    Fischer JE; Snyder SH
    Surg Forum; 1965; 16():331-2. PubMed ID: 5835179
    [No Abstract]   [Full Text] [Related]  

  • 59. Peptic ulcer disease and gastric hypersecretion following portacaval shunt.
    Gudis S
    Mt Sinai J Med; 1976; 43(5):593-601. PubMed ID: 1086969
    [No Abstract]   [Full Text] [Related]  

  • 60. Nature of the humoral agent responsible for portacaval shunt-related gastric hypersecretion in man.
    Orloff MJ; Abbott AG; Rosen H
    Am J Surg; 1970 Aug; 120(2):237-43. PubMed ID: 5456411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.